Advanced gastric cancer: What we know and what we still have to learn - sprookjes - yvandenbroek - TriplyDB

Advanced gastric cancer: What we know and what we still have to learn

Advanced gastric cancer: What we know and what we still have to learn

http://www.wikidata.org/entity/Q26774528

about

Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer Inductions of Caspase-, MAPK- and ROS-dependent Apoptosis and Chemotherapeutic Effects Caused by an Ethanol Extract of Scutellaria barbata D. Don in Human Gastric Adenocarcinom Cells.CA125 is a potential biomarker to predict surgically incurable gastric and cardia cancer: A retrospective study.The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer.Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea-(NMU) induced gastric cancer in rats.CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.

P2860

Q33895603-2FEC8325-0B60-4F45-9713-7FCCF73F50ED Q36329068-E02A7FFA-0BB1-4E00-98F7-ADF14ACC6558 Q37061127-3DD06099-425D-43E2-87F2-6F0A77D2FACD Q37530507-45C4E133-D393-427F-9456-75C2858E3626 Q38689450-26E8FE17-8746-4940-B4ED-6D66E7C9FF70 Q38767113-40411498-7A0F-4BCC-A9F0-1C465424016E Q47096468-31903DCC-B5A9-4F47-B1E6-261AC7C8DE1E Q52565789-AE47BD68-69D2-407B-99BA-DE734E5087BC

P2860

Advanced gastric cancer: What we know and what we still have to learn

http://www.wikidata.org/entity/Q26774528

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Advanced gastric cancer: What we know and what we still have to learn

@ast

Advanced gastric cancer: What we know and what we still have to learn

@en

Advanced gastric cancer: What we know and what we still have to learn

@nl

type

label

Advanced gastric cancer: What we know and what we still have to learn

@ast

Advanced gastric cancer: What we know and what we still have to learn

@en

Advanced gastric cancer: What we know and what we still have to learn

@nl

prefLabel

Advanced gastric cancer: What we know and what we still have to learn

@ast

Advanced gastric cancer: What we know and what we still have to learn

@en

Advanced gastric cancer: What we know and what we still have to learn

@nl

P1433

Q26774528-92EC8A6D-277D-4BB7-B23F-C95B04F796D3

P1476

Q26774528-19CD538B-0870-4133-9C52-632939D0D203

P2093

Q26774528-212E18D4-E931-436D-8AA0-7404E7F1164F

Q26774528-4076507D-2980-44C1-B542-676103F22AC9

Q26774528-53803728-558A-4513-A865-83E73EEEED30

Q26774528-5CEA96E4-3BEC-4899-8E9E-A5AE6568DAC3

Q26774528-C34D5E11-3041-4457-980F-A99923104A8E

Q26774528-D07BD347-3C33-4E3C-BCFC-B13AF69A61A1

Q26774528-DB00FC2C-01F8-4725-93FF-9DEE006D4016

Q26774528-F768D152-7596-4123-A8C0-7B2FCFC34B0E

Q26774528-F8B0DA1C-F3AB-4385-8E28-E801D63323E9

P2860

Q26774528-083F1926-23D6-4AF7-A1A8-FFFD7E944AD8

Q26774528-0899078B-5173-4C14-904C-87408315AC02

Q26774528-0EAFEAB8-4467-4653-BF83-EDF774090D59

Q26774528-0FE09890-B238-462D-817C-A45A73120831

Q26774528-1196323C-6286-4F24-BC33-673A99C19011

Q26774528-16ECD279-59F9-44A2-9ECB-1F54054D6143

Q26774528-1A5FE899-6E2C-4C06-99C8-E9AD1E75F64F

Q26774528-1B020C1B-F179-42D1-87FE-840DE2A7AC60

Q26774528-1F086BBE-B897-432F-9D42-89C1A03E930C

Q26774528-1F981396-B206-432C-ABDD-8DF5CBAE607E

P304

Q26774528-2770F3E5-8C87-416D-ADCD-ACF99FD05DF6

P31

Q26774528-A0456460-4579-4408-B1E7-2ACF50DDAAAA

P3181

Q26774528-F8F5D6C7-9D5D-4536-A2F4-FAC2CFD99395

P356

Q26774528-35313CB7-FF42-41EE-B8B7-5268F483F909

P407

Q26774528-16C8B911-E77A-4081-B823-9A33CD4B2962

P433

Q26774528-242BF8AE-ACAC-46C8-B032-45E771EFCE3D

P478

Q26774528-53421C38-8E59-4CED-BA72-0D2C5F27211B

P577

Q26774528-61DA0EE0-09AB-45A1-9C77-74CB024526CF

P5875

Q26774528-6B1F1D1B-EF2D-476C-87ED-8C748D8E4BC0

P698

Q26774528-D75620AF-AC0C-4D11-9DF3-B3E46083DE10

P932

Q26774528-E57C3EB5-6C5C-4123-BA8D-2105E183AA81

P3181

P356

WJG.V22.I3.1139

P1433

World Journal of Gastroenterology

P1476

Advanced gastric cancer: What we know and what we still have to learn

@en

P2093

Arianna Heyer

http://www.w3.org/2001/XMLSchema#string

Fausto Catena

http://www.w3.org/2001/XMLSchema#string

Federico Coccolini

http://www.w3.org/2001/XMLSchema#string

Gabriela E Nita

http://www.w3.org/2001/XMLSchema#string

Giulia Montori

http://www.w3.org/2001/XMLSchema#string

Luca Ansaloni

http://www.w3.org/2001/XMLSchema#string

Marco Ceresoli

http://www.w3.org/2001/XMLSchema#string

Maria Carla Valli

http://www.w3.org/2001/XMLSchema#string

Simona Cima

http://www.w3.org/2001/XMLSchema#string

P2860

Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus

Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach

Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.

Comparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differences

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

P304

1139-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1147115

http://www.w3.org/2001/XMLSchema#string

P356

10.3748/WJG.V22.I3.1139

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290649323

http://www.w3.org/2001/XMLSchema#string

P698

26811653

http://www.w3.org/2001/XMLSchema#string

P932

4716026

http://www.w3.org/2001/XMLSchema#string